Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
It transformed obesity treatment as the first weekly GLP-1 for chronic weight management and currently supports nearly 1.5 million patients in the U.S
Using Whether you qualify may depend on your overall health, including your current blood sugar control, medical history, and any existing health conditions
Last reviewed: April 21, 2026 Updated with Phase 3 TRIUMPH-4 data Primary sources: NEJM, Eli Lilly, ClinicalTrials.gov Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) currently in Phase 3 trials, showing stronger early weight loss data
A sudden or worst-ever headache
Step 2: Application of Carbon Lotion A thin layer of activated liquid carbon is applied across your face
US$ 24.57
US$ 20.02
US$ 27.24
US$ 22.46
US$ 28.98
US$ 23.57
